Ascendant Solutions Inc. reported earnings results for the second quarter and six months ended June 30, 2009. The company reported a consolidated net loss of $55,000 for the fiscal quarter ended June 30, 2009, compared to net income of $1,671,000 in 2008, resulting in net loss per share of less than $0.01 compared to net income per share of $0.07. For the fiscal quarter ended June 30, 2009, the company reported Consolidated Earnings before Interest, Taxes, Depreciation and Amortization of $59,000 compared to consolidated EBITDA of $271,000 in the second quarter of 2008. For the six months ended June 30, 2009, consolidated net income was $148,000, compared to $1,409,000 for the six months ended 2008, resulting in net EPS of $0.01 compared to $0.06. Results for 2008 include the $1,714,000 gain on sale of discontinued Medicine Man Pharmacies operations, which the company sold to Pharmacy Operations Inc. on April 11, 2008. EBITDA for the six months ended June 30, 2009, was $369,000 compared to ($3,000) for the same period of 2008.

Ascendant Solutions Inc. announced earnings results for the first quarter ended March 31, 2009. Consolidated net income for the fiscal quarter ended March 31, 2009 increased $465,000, or approximately 178% to net income of $203 000, compared to a net loss of $262,000 in 2008, resulting in net earnings per share of $0.01 compared to net loss per share of $0.01. For the fiscal quarter ended March 31, 2009, the company reported consolidated EBITDA of $310,000 compared to consolidated negative EBITDA of $274,000 in 2008, an increase of $584,000 or approximately 213%.

Ascendant Solutions Inc. reported unaudited consolidated earnings results for the year ended December 31, 2008. For the year, the company reported consolidated net income increased $1,301,000 or approximately 28.6% to net income of $5,844,000 compared to net income of $4,543,000 in 2007, resulting in net earnings per basic and fully diluted share of $0.25 compared to $0.20. Consolidated EBITDA of $131,000 compared to consolidated EBITDA of $2,935,000 in 2007. Basic and fully diluted net income from continuing operations per share was $0.18 against $0.14 in the last year.